{"id":"W4411643312","doi":"10.1016/j.esmoop.2025.105187","title":"58TiP ASCENT-GYN-01 (GOG-3104/ENGOT-en26): A randomized, phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with endometrial cancer (EC) after platinum-based chemotherapy and immunotherapy","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Gilead Sciences","keywords":"Medicine; Endometrial cancer; Gynecology; Cancer; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001187134,0.001225212,0.001213419,0.0003754491,0.0002554471,0.0008220264,0.0006738164,0.001291491,0.007750547],"category_scores_gemma":[0.0007710478,0.0004753851,0.001203577,0.0003453367,0.0008548725,0.0006154895,0.0002866187,0.002988903,0.001372338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007061771,"about_ca_system_score_gemma":0.0009567919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001067182,"about_ca_topic_score_gemma":0.002910658,"domain_scores_codex":[0.9997277,0.0001474072,0.00000888705,0.00003988107,0.00002051584,0.00005563499],"domain_scores_gemma":[0.99962,0.00008126238,0.00006706562,0.00002791738,0.0000188396,0.000184933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.920408,0.02483147,0.001444013,0.000550174,0.0007045569,0.00008035883,0.00007803849,0.001081956,0.00779543,0.0003304222,0.0031194,0.03957614],"study_design_scores_gemma":[0.8304943,0.1624642,0.002781438,0.00003249949,0.0003052659,0.00006505055,0.00003017239,0.0006290452,0.0007916435,0.0001937969,0.002198382,0.00001419363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854606,0.002712597,0.0005681624,0.0008371222,0.0004068858,0.003935199,0.001783406,0.0001514283,0.004144674],"genre_scores_gemma":[0.9788365,0.002747362,0.001868131,0.001604438,0.0002878741,0.003655198,0.003155281,0.00005130607,0.007794008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007750547,"threshold_uncertainty_score":0.02592814,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01580445498523225,"score_gpt":0.3299195637676139,"score_spread":0.3141151087823816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}